Back to Search
CARLOS PLASENCIA, M.D.
M.D.
Family Medicine Physician
NPI: 1619054400Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
J2737(TX)
Research & Publications (12)
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines.
PMID 19372549·Mol Cancer Ther·2009
8-other
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
PMID 19296535·Int J Cancer·2009
8-other
Elucidation of the molecular mechanisms of a salicylhydrazide class of compounds by proteomic analysis.
PMID 19275759·Curr Cancer Drug Targets·2009
8-other
Discovery of a novel quinoxalinhydrazide with a broad-spectrum anticancer activity.
PMID 19221468·Cancer Biol Ther·2009
7-preclinical
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
PMID 16773204·Int J Oncol·2006
4-observational
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines.
PMID 16020668·Mol Cancer Ther·2005
7-preclinical
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
PMID 15715477·J Med Chem·2005
7-preclinical
Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
PMID 15292710·Invest New Drugs·2004
4-observational
Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors.
PMID 15185725·Antivir Chem Chemother·2004
8-other
Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms.
PMID 12684658·Int J Oncol·2003
8-other
Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines.
PMID 10857993·Invest New Drugs·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2223 WEST LOOP S
HOUSTON, TX 77027 - Phone
- (956) 371-0900
Quick Facts
- NPI
- 1619054400
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 12
Are you this provider?
Claim Your Profile